Akebia Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
32,556.50
108,918.00
138,454.00
260,343.00
317,792.00
322
Total Accounts Receivable
135.30
48.00
-
33,823.00
34,216.00
17
Other Current Assets
739.20
1,514.00
2,563.00
2,155.00
6,348.00
16
Total Current Assets
33,431.00
110,480.00
141,017.00
296,321.00
358,356.00
468
Net Property, Plant & Equipment
30.40
210.00
540.00
2,612.00
3,617.00
8
Other Assets
1,203.50
305.00
1,383.00
1,283.00
2,274.00
135
Total Assets
34,664.90
110,995.00
142,940.00
300,216.00
364,247.00
1,109
ST Debt & Current Portion LT Debt
3.90
-
8.00
9.00
-
Income Tax Payable
-
-
-
-
987.00
Other Current Liabilities
3,897.90
6,885.00
11,860.00
114,259.00
143,362.00
Total Current Liabilities
3,901.80
6,885.00
11,868.00
114,268.00
144,349.00
Long-Term Debt
8.00
-
6.00
5.00
-
Other Liabilities
-
32.00
68.00
117,823.00
100,567.00
Total Liabilities
3,909.80
6,917.00
11,942.00
232,096.00
244,916.00
Common Equity (Total)
127,072.10
104,078.00
130,998.00
68,120.00
119,331.00
Total Shareholders' Equity
30,755.10
104,078.00
130,998.00
68,120.00
119,331.00
Total Equity
30,755.10
104,078.00
130,998.00
68,120.00
119,331.00
Liabilities & Shareholders' Equity
34,664.90
110,995.00
142,940.00
300,216.00
364,247.00
Preferred Stock (Carrying Value)
157,827.10
-
-
-
-
About Akebia Therapeutics
View Profile
